Exact Mass: 678.4648

Descladinose roxithromycin

C33H62N2O12 (678.4303)

Descladinose roxithromycin is a metabolite of roxithromycin. Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. However, an N-oxime side chain is attached to the lactone ring. It is also currently undergoing clinical trials for the treatment of male-pattern hair loss. (Wikipedia)

PA(14:0/18:1(12Z)-2OH(9,10))

C35H67O10P (678.4472)

PA(14:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/14:0)

C35H67O10P (678.4472)

PA(18:1(12Z)-2OH(9,10)/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/14:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-14:0/18:1(12Z)-2OH(9,10))

C35H67O10P (678.4472)

PA(i-14:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/i-14:0)

C35H67O10P (678.4472)

PA(18:1(12Z)-2OH(9,10)/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/i-14:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

DG(17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(17:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/17:0/0:0)

C40H70O8 (678.507)

DG(PGE2/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(17:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/17:0)

C40H70O8 (678.507)

DG(PGE2/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(17:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/17:0/0:0)

C40H70O8 (678.507)

DG(PGD2/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(17:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/17:0)

C40H70O8 (678.507)

DG(PGD2/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/17:0/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/17:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(a-17:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/a-17:0/0:0)

C40H70O8 (678.507)

DG(PGE2/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(a-17:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/a-17:0)

C40H70O8 (678.507)

DG(PGE2/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(a-17:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/a-17:0/0:0)

C40H70O8 (678.507)

DG(PGD2/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(a-17:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/a-17:0)

C40H70O8 (678.507)

DG(PGD2/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(a-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-17:0/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(a-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-17:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(i-17:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-17:0/0:0)

C40H70O8 (678.507)

DG(PGE2/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(i-17:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-17:0)

C40H70O8 (678.507)

DG(PGE2/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(i-17:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-17:0/0:0)

C40H70O8 (678.507)

DG(PGD2/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(i-17:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-17:0)

C40H70O8 (678.507)

DG(PGD2/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(i-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-17:0/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(i-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-17:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Kahiricoside IV

C38H62O10 (678.4343)

Rubiarboside A

C38H62O10 (678.4343)

Kahiricoside III

C38H62O10 (678.4343)

Depressoside B

C38H62O10 (678.4343)

Eryloside U

C38H62O10 (678.4343)

(1R,2R,4aS,6aS,8R,9R,10aS,12aS)-9-acetoxy-2-{(1R)-1,2-dimethylpropyl}-2,4a,7,7,10a,12a-hexamethyl-8-(beta-D-glucopyranosyloxy)-1,2.3.4,4a,5,6,6a,7,8,9,10,10a,11,12,12a-hexadecahydrochrysene-1-carboxylic acid|FR207944|fuscoatroside

C38H62O10 (678.4343)

klysimplexin I

C40H70O8 (678.507)

cumingianoside N

C38H62O10 (678.4343)

physordinose A

C34H62O13 (678.419)

iejimalide A

C40H58N2O7 (678.4244)

Cumingianodide F

C38H62O10 (678.4343)

O19-Methyl-,O21-Ac-Bafilomycin A1

C38H62O10 (678.4343)

10-acetoxy-4-acetyl-28-hydroraspacionin

C38H62O10 (678.4343)

(23E)-(12R,20S)-12,20-dihydroxy-25-methoxy-3,4-secodammara-4(28),23-dien-3-oic acid ethyl ester 12-O-beta-D-quinovopyranoside|cyclocarioside E

C39H66O9 (678.4707)

DTXSID60346618

C46H62O4 (678.4648)

C38H62O10

C38H62O10 (678.4343)

Thermoactinoamide_J

C36H66N6O6 (678.5044)

PG(12:0/17:1(9Z))

C35H67O10P (678.4472)

PG(13:0/16:1(9Z))

C35H67O10P (678.4472)

PG(14:0/15:1(9Z))

C35H67O10P (678.4472)

PG(14:1(9Z)/15:0)

C35H67O10P (678.4472)

PG(15:0/14:1(9Z))

C35H67O10P (678.4472)

PG(15:1(9Z)/14:0)

C35H67O10P (678.4472)

PG(16:1(9Z)/13:0)

C35H67O10P (678.4472)

PG(17:1(9Z)/12:0)

C35H67O10P (678.4472)

PG(O-16:0/14:1(9Z))

C36H71O9P (678.4835)

PG(P-16:0/14:0)

C36H71O9P (678.4835)

PG(P-18:0/12:0)

C36H71O9P (678.4835)

PA(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C38H63O8P (678.426)

PA(15:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

C38H63O8P (678.426)

PA(17:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))

C38H63O8P (678.426)

PA(18:4(6Z,9Z,12Z,15Z)/17:2(9Z,12Z))

C38H63O8P (678.426)

PA(20:5(5Z,8Z,11Z,14Z,17Z)/15:1(9Z))

C38H63O8P (678.426)

PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/13:0)

C38H63O8P (678.426)

PA(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))

C39H67O7P (678.4624)

PG 29:1

C35H67O10P (678.4472)

PG O-30:1

C36H71O9P (678.4835)

PA 35:6

C38H63O8P (678.426)

PA O-36:6

C39H67O7P (678.4624)

pa66

C36H66N6O6 (678.5044)

5,11,17,25-Tetrakis(2-methyl-2-propanyl)-21-oxapentacyclo[21.3.1.13,7.19,13.115,19]triaconta-1(27),3(30),4,6,9(29),10,12,15(28),16,18,23,25-dodecaene-27,28,29,30-tetrol

C45H58O5 (678.4284)

Dimyristoylphosphatidylcholine

C36H73NO8P+ (678.5074)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

Peniciside

C38H62O10 (678.4343)

Phosphatidylserine (1,2-dimyristoyl)

C34H65NO10P- (678.4346)

DMPC;L-beta,gamma-Dimyristoyl-alpha-lecithin

C36H73NO8P+ (678.5074)

PA(14:0/18:1(12Z)-2OH(9,10))

C35H67O10P (678.4472)

PA(18:1(12Z)-2OH(9,10)/14:0)

C35H67O10P (678.4472)

PA(i-14:0/18:1(12Z)-2OH(9,10))

C35H67O10P (678.4472)

PA(18:1(12Z)-2OH(9,10)/i-14:0)

C35H67O10P (678.4472)

DG(17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(PGE2/17:0/0:0)

C40H70O8 (678.507)

DG(17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(PGE2/0:0/17:0)

C40H70O8 (678.507)

DG(17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(PGD2/17:0/0:0)

C40H70O8 (678.507)

DG(17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(PGD2/0:0/17:0)

C40H70O8 (678.507)

DG(a-17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(PGE2/a-17:0/0:0)

C40H70O8 (678.507)

DG(a-17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(PGE2/0:0/a-17:0)

C40H70O8 (678.507)

DG(a-17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(PGD2/a-17:0/0:0)

C40H70O8 (678.507)

DG(a-17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(PGD2/0:0/a-17:0)

C40H70O8 (678.507)

DG(i-17:0/PGE2/0:0)

C40H70O8 (678.507)

DG(PGE2/i-17:0/0:0)

C40H70O8 (678.507)

DG(i-17:0/0:0/PGE2)

C40H70O8 (678.507)

DG(PGE2/0:0/i-17:0)

C40H70O8 (678.507)

DG(i-17:0/PGD2/0:0)

C40H70O8 (678.507)

DG(PGD2/i-17:0/0:0)

C40H70O8 (678.507)

DG(i-17:0/0:0/PGD2)

C40H70O8 (678.507)

DG(PGD2/0:0/i-17:0)

C40H70O8 (678.507)

DG(17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/17:0/0:0)

C40H70O8 (678.507)

DG(17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/17:0)

C40H70O8 (678.507)

DG(a-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-17:0/0:0)

C40H70O8 (678.507)

DG(a-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-17:0)

C40H70O8 (678.507)

DG(i-17:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-17:0/0:0)

C40H70O8 (678.507)

DG(i-17:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C40H70O8 (678.507)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-17:0)

C40H70O8 (678.507)

(1R,2R,4aS,6aR,8R,9R,10aS,12aS)-9-(acetyloxy)-8-(beta-D-glucopyranosyloxy)-2,4a,7,7,10a,12a-hexamethyl-2-[(2R)-3-methylbutan-2-yl]-1,2,3,4,4a,5,6,6a,7,8,9,10,10a,11,12,12a-hexadecahydrochrysene-1-carboxylic acid

C38H62O10 (678.4343)

cyclo[OVal-Pro-N(Me)Val-ObAla(2S-Me,3R-pentyl)-Val-N(Me)Val]

C36H62N4O8 (678.4567)

Cumingianoside F

C38H62O10 (678.4343)

A triterpenoid saponin that is 24,25-epoxy-13,30-cyclodammarane-3,7,23-triol attached to a 6-O-acetyl-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. Isolated from Dysoxylum cumingianum it exhibits antileukemic activity.

2-[[(2R)-2-dodecanoyloxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[[(2R)-3-decanoyloxy-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[[(2R)-3-dodecanoyloxy-2-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

Mgdg O-26:5_4:0

C39H66O9 (678.4707)

Mgdg O-8:0_22:5

C39H66O9 (678.4707)

Mgdg O-22:5_8:0

C39H66O9 (678.4707)

Mgdg O-24:5_6:0

C39H66O9 (678.4707)

Mgdg O-28:5_2:0

C39H66O9 (678.4707)

Mgdg O-10:0_20:5

C39H66O9 (678.4707)

Mgdg O-16:4_14:1

C39H66O9 (678.4707)

Mgdg O-18:5_12:0

C39H66O9 (678.4707)

Mgdg O-14:1_16:4

C39H66O9 (678.4707)

Mgdg O-12:0_18:5

C39H66O9 (678.4707)

Mgdg O-20:5_10:0

C39H66O9 (678.4707)

PE-Cer 12:2;2O/24:4

C38H67N2O6P (678.4736)

PE-Cer 18:2;2O/18:4

C38H67N2O6P (678.4736)

PE-Cer 12:0;2O/24:6

C38H67N2O6P (678.4736)

PE-Cer 14:0;2O/22:6

C38H67N2O6P (678.4736)

PE-Cer 14:1;2O/22:5

C38H67N2O6P (678.4736)

PE-Cer 16:1;2O/20:5

C38H67N2O6P (678.4736)

PE-Cer 16:2;2O/20:4

C38H67N2O6P (678.4736)

PE-Cer 18:3;2O/18:3

C38H67N2O6P (678.4736)

PE-Cer 20:3;2O/16:3

C38H67N2O6P (678.4736)

PE-Cer 18:1;2O/18:5

C38H67N2O6P (678.4736)

PE-Cer 14:2;2O/22:4

C38H67N2O6P (678.4736)

PE-Cer 20:2;2O/16:4

C38H67N2O6P (678.4736)

PE-Cer 14:3;2O/22:3

C38H67N2O6P (678.4736)

PE-Cer 16:3;2O/20:3

C38H67N2O6P (678.4736)

PE-Cer 12:1;2O/24:5

C38H67N2O6P (678.4736)

[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-pentadec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] tetradecanoate

C36H71O9P (678.4835)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-nonadec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] heptadecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] hexadecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] tridecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-tridec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] undecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] pentadecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (Z)-tetradec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (Z)-octadec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] dodecanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] decanoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-heptadec-9-enoate

C36H71O9P (678.4835)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (Z)-hexadec-9-enoate

C36H71O9P (678.4835)

[2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyheptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H66O6 (678.4859)

PMeOH 18:2_16:4

C38H63O8P (678.426)

PEtOH 17:2_16:4

C38H63O8P (678.426)

PMeOH 16:3_18:3

C38H63O8P (678.426)

PEtOH 15:1_18:5

C38H63O8P (678.426)

PMeOH 16:1_18:5

C38H63O8P (678.426)

PMeOH 14:1_20:5

C38H63O8P (678.426)

PEtOH 13:1_20:5

C38H63O8P (678.426)

PMeOH 16:2_18:4

C38H63O8P (678.426)

PMeOH 12:0_22:6

C38H63O8P (678.426)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C38H62O10 (678.4343)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C38H62O10 (678.4343)

[1-[(Z)-tridec-9-enoyl]oxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H62O10 (678.4343)

[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C38H62O10 (678.4343)

[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C38H67N2O6P (678.4736)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-docos-13-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-henicos-11-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexacos-15-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] pentadecanoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] hexadecanoate

C35H67O10P (678.4472)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-heptadec-9-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tetradecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C35H67O10P (678.4472)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C35H67O10P (678.4472)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-nonadec-9-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-icos-11-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-docos-13-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C35H67O10P (678.4472)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C35H67O10P (678.4472)

[1-[(Z)-heptadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C38H63O8P (678.426)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C38H63O8P (678.426)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate

C38H63O8P (678.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C35H67O10P (678.4472)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] hexadecanoate

C35H67O10P (678.4472)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C38H63O8P (678.426)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C38H63O8P (678.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C35H67O10P (678.4472)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentadecanoate

C35H67O10P (678.4472)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C35H67O10P (678.4472)

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C38H63O8P (678.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C35H67O10P (678.4472)

2-[hydroxy-[(2R)-3-pentadecanoyloxy-2-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

[1-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (7Z,9Z)-tetradeca-7,9-dienoate

C43H66O6 (678.4859)

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate

C43H66O6 (678.4859)

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (5Z,7Z,9Z,11Z,13Z)-hexadeca-5,7,9,11,13-pentaenoate

C43H66O6 (678.4859)

2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate

C43H66O6 (678.4859)

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (4Z,7Z)-hexadeca-4,7-dienoate

C43H66O6 (678.4859)

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate

C43H66O6 (678.4859)

[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (5Z,7Z,9Z,11Z,13Z)-hexadeca-5,7,9,11,13-pentaenoate

C43H66O6 (678.4859)

[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate

C43H66O6 (678.4859)

2-[(3-Decanoyloxy-2-octadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[[(2R)-2-heptadecanoyloxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[(3-Dodecanoyloxy-2-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[hydroxy-[(2R)-2-pentadecanoyloxy-3-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[(2-Heptadecanoyloxy-3-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[Hydroxy-(2-pentadecanoyloxy-3-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[(2-Henicosanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[Hydroxy-(2-icosanoyloxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[Hydroxy-(2-nonadecanoyloxy-3-nonanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tetradecanoyloxypropyl] (E)-pentadec-9-enoate

C35H67O10P (678.4472)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-9-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] octadec-17-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-11-enoate

C35H67O10P (678.4472)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C38H63O8P (678.426)

2-[[(2S)-3-heptadecanoyloxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-11-enoate

C35H67O10P (678.4472)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

C38H63O8P (678.426)

[1-tridecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C38H62O10 (678.4343)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-7-enoate

C35H67O10P (678.4472)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-4-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] pentadecanoate

C35H67O10P (678.4472)

[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C38H63O8P (678.426)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-7-enoate

C35H67O10P (678.4472)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C38H63O8P (678.426)

2-[[(2S)-2-decanoyloxy-3-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

[1-[(E)-tridec-8-enoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C38H62O10 (678.4343)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tridecanoyloxypropyl] (E)-hexadec-9-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-6-enoate

C35H67O10P (678.4472)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-13-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-9-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-4-enoate

C35H67O10P (678.4472)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C38H63O8P (678.426)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C38H63O8P (678.426)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C38H63O8P (678.426)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (7E,9E)-nonadeca-7,9-dienoate

C38H63O8P (678.426)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] octadec-17-enoate

C35H67O10P (678.4472)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tridecanoyloxypropyl] (E)-hexadec-7-enoate

C35H67O10P (678.4472)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C35H67O10P (678.4472)

[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C38H63O8P (678.426)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (E)-heptadec-9-enoate

C35H67O10P (678.4472)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-octadec-6-enoate

C35H67O10P (678.4472)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-nonadec-9-enoate

C38H63O8P (678.426)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] pentadecanoate

C35H67O10P (678.4472)

[(2R)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C38H63O8P (678.426)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-octadec-13-enoate

C35H67O10P (678.4472)

[(2R)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C38H63O8P (678.426)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-heptadec-9-enoate

C35H67O10P (678.4472)

2-[(3-Acetyloxy-2-hexacosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[(2-Docosanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[Hydroxy-(3-pentanoyloxy-2-tricosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[(3-Butanoyloxy-2-tetracosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[Hydroxy-(2-pentacosanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C36H73NO8P+ (678.5074)

2-[carboxy-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C39H68NO8+ (678.4945)

2-[[2-butanoyloxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C38H65NO7P+ (678.4498)

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C38H65NO7P+ (678.4498)

2-[carboxy-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-tridecanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C39H68NO8+ (678.4945)

2-[carboxy-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-nonanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C39H68NO8+ (678.4945)

2-[carboxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-undecanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C39H68NO8+ (678.4945)

2-[[2-acetyloxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C38H65NO7P+ (678.4498)

Descladinose roxithromycin

C33H62N2O12 (678.4303)

1-hexadecyl-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C36H71O9P (678.4835)

1-dodecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C35H67O10P (678.4472)

phosphatidylserine 28:0(1-)

C34H65NO10P (678.4346)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 28 carbons in total and 0 double bonds.

lejimalide A

C40H58N2O7 (678.4244)

A macrolide that is isolated from the marine tunicate Eudistoma cf. rigida and exhibits potent in vitro cytotoxic activity.

Veraguamide J

C36H62N4O8 (678.4567)

A natural product found in Oscillatoria margaritifera PAC-17-FEB-10-2.

FR207944

C38H62O10 (678.4343)

A triterpene glycoside with strong antifungal activity against Aspergillus fumigatus and Candida albicans. It is isolated from natural Chaetomium sp.no.217.

TG(40:8)

C43H66O6 (678.4859)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

BisMePA(34:6)

C39H67O7P (678.4624)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 21:7/O-25:7

C46H62O4 (678.4648)

FAHFA 22:7/O-24:7

C46H62O4 (678.4648)

FAHFA 23:7/O-23:7

C46H62O4 (678.4648)

FAHFA 24:7/O-22:7

C46H62O4 (678.4648)

FAHFA 25:7/O-21:7

C46H62O4 (678.4648)

MGDG O-29:6;O

C38H62O10 (678.4343)

MGDG O-30:5

C39H66O9 (678.4707)

MGMG 30:5

C39H66O9 (678.4707)

MGGA 29:5

C38H62O10 (678.4343)

PA O-14:0/22:6

C39H67O7P (678.4624)

PA O-14:1/22:5

C39H67O7P (678.4624)

PA O-16:1/20:5

C39H67O7P (678.4624)

PA O-16:2/20:4

C39H67O7P (678.4624)

PA O-18:2/18:4

C39H67O7P (678.4624)

PA O-20:0/12:2;O3

C35H67O10P (678.4472)

PA O-32:2;O3

C35H67O10P (678.4472)

PA P-14:0/22:5

C39H67O7P (678.4624)

PA P-14:0/22:5 or PA O-14:1/22:5

C39H67O7P (678.4624)

PA P-16:0/20:5

C39H67O7P (678.4624)

PA P-16:0/20:5 or PA O-16:1/20:5

C39H67O7P (678.4624)

PA P-16:1/20:4

C39H67O7P (678.4624)

PA P-16:1/20:4 or PA O-16:2/20:4

C39H67O7P (678.4624)

PA P-18:1/18:4

C39H67O7P (678.4624)

PA P-18:1/18:4 or PA O-18:2/18:4

C39H67O7P (678.4624)

PA P-36:5

C39H67O7P (678.4624)

PA P-36:5 or PA O-36:6

C39H67O7P (678.4624)

PA 14:0/18:1;O2

C35H67O10P (678.4472)

PA 32:1;O2

C35H67O10P (678.4472)

PA 13:0_22:6

C38H63O8P (678.426)

PA 15:1_20:5

C38H63O8P (678.426)

PA 17:2_18:4

C38H63O8P (678.426)

PG O-14:0/16:1

C36H71O9P (678.4835)

PG O-14:1/16:0

C36H71O9P (678.4835)

PG O-16:0/14:1

C36H71O9P (678.4835)

PG O-16:1/14:0

C36H71O9P (678.4835)

PG O-18:0/11:2;O

C35H67O10P (678.4472)

PG O-18:1/12:0

C36H71O9P (678.4835)

PG O-20:1/10:0

C36H71O9P (678.4835)

PG O-29:2;O

C35H67O10P (678.4472)

PG P-14:0/16:0

C36H71O9P (678.4835)

PG P-14:0/16:0 or PG O-14:1/16:0

C36H71O9P (678.4835)

PG P-16:0/14:0

C36H71O9P (678.4835)

PG P-16:0/14:0 or PG O-16:1/14:0

C36H71O9P (678.4835)

PG P-18:0/12:0

C36H71O9P (678.4835)

PG P-18:0/12:0 or PG O-18:1/12:0

C36H71O9P (678.4835)

PG P-20:0/10:0

C36H71O9P (678.4835)

PG P-20:0/10:0 or PG O-20:1/10:0

C36H71O9P (678.4835)

PG P-20:0/9:1;O

C35H67O10P (678.4472)

PG P-30:0

C36H71O9P (678.4835)

PG P-30:0 or PG O-30:1

C36H71O9P (678.4835)

PG 11:0_18:1

C35H67O10P (678.4472)

PG 12:0_17:1

C35H67O10P (678.4472)

PG 13:0_16:1

C35H67O10P (678.4472)

PG 14:0_15:1

C35H67O10P (678.4472)

PG 14:1_15:0

C35H67O10P (678.4472)

PG 25:0/4:1

C35H67O10P (678.4472)

PG 3:0_26:1

C35H67O10P (678.4472)

LPEth 34:6

C39H67O7P (678.4624)

PEth 31:0;O

C36H71O9P (678.4835)

PEth 33:6

C38H63O8P (678.426)

PM 32:0;O

C36H71O9P (678.4835)

PM 34:6

C38H63O8P (678.426)

CerPE 14:0;O2/22:6

C38H67N2O6P (678.4736)

CerPE 14:1;O2/22:5

C38H67N2O6P (678.4736)

CerPE 14:2;O2/22:4

C38H67N2O6P (678.4736)

CerPE 16:1;O2/20:5

C38H67N2O6P (678.4736)

CerPE 16:2;O2/20:4

C38H67N2O6P (678.4736)

CerPE 18:2;O2/18:4

C38H67N2O6P (678.4736)

CerPE 36:6;O2

C38H67N2O6P (678.4736)

SM 15:2;O2/18:4

C38H67N2O6P (678.4736)

SM 33:6;O2

C38H67N2O6P (678.4736)

CAE 19:5

C43H66O6 (678.4859)

PMe(34:6)

C38H63O8P (678.426)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

[(2r,3s,4s,5r,6r)-6-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C38H62O10 (678.4343)

2-{[9,14-dihydroxy-15-(7-hydroxy-6-methylhept-5-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate

C38H62O10 (678.4343)

2-o-acetyl-28-dehydroxy-rubianoside iv

C38H62O10 (678.4343)

{"Ingredient_id": "HBIN006168","Ingredient_name": "2-o-acetyl-28-dehydroxy-rubianoside iv","Alias": "NA","Ingredient_formula": "C38H62O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "371","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-(acetyloxy)-6-{2-[3,7-bis(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C38H62O10 (678.4343)

8-ethyl-11,19-dihydroxy-20-[5'-(1-hydroxyethyl)-2,5'-dimethyl-[2,2'-bioxolan]-5-yl]-2,4,6,12,14,18-hexamethyl-9-oxoicosa-10,16-dienoic acid

C40H70O8 (678.507)

(2s,4s,6s,8s,10z,12r,14r,16e,18s,19s)-8-ethyl-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,12,14,18-hexamethyl-9-oxoicosa-10,16-dienoic acid

C40H70O8 (678.507)

(1r,3s,3as,5as,5bs,6s,7as,9r,10r,11as,13ar,13bs)-1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-10-yl acetate

C38H62O10 (678.4343)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8s,9s,11r,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate

C38H62O10 (678.4343)

(2s)-n-[(2e,4e)-5-[(2s,3s,4e,6e,8s,11z,13e,16s,17e,19e,21r,22e)-8,16-dimethoxy-3,12,18,21-tetramethyl-24-oxo-1-oxacyclotetracosa-4,6,11,13,17,19,22-heptaen-2-yl]-2-methylhexa-2,4-dien-1-yl]-3-hydroxy-2-[(hydroxymethylidene)amino]propanimidic acid

C40H58N2O7 (678.4244)

[6-({15-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-7-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C38H62O10 (678.4343)

(6-{[9,14-dihydroxy-15-(7-hydroxy-6-methylhept-5-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl acetate

C38H62O10 (678.4343)

(1r,2r,4as,6ar,8r,9r,10as,12as)-9-(acetyloxy)-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,5,6,6a,8,9,10,11,12-decahydro-1h-chrysene-1-carboxylic acid

C38H62O10 (678.4343)

(2r,4r,6r,10z,12s,14s,16e,18r)-8-ethyl-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,12,14,18-hexamethyl-9-oxoicosa-10,16-dienoic acid

C40H70O8 (678.507)

1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-10-yl acetate

C38H62O10 (678.4343)

(1r,3s,3as,5as,5bs,6s,7ar,9r,10r,11as,13ar,13bs)-1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-10-yl acetate

C38H62O10 (678.4343)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4r,5r)-2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-3-(2-methylpropoxy)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-(2-methylpropoxy)oxan-3-yl dodecanoate

C34H62O13 (678.419)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14r,15r,16r)-9,14-dihydroxy-15-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate

C38H62O10 (678.4343)

(1r,3s,3as,5as,5bs,6s,7ar,9r,10r,11as,13ar,13bs)-1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-9-{[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-10-yl acetate

C38H62O10 (678.4343)

2-({2-[(acetyloxy)methyl]-4-hydroxy-5-(hydroxymethyl)-3-(2-methylpropoxy)oxolan-2-yl}oxy)-5-hydroxy-6-(hydroxymethyl)-4-(2-methylpropoxy)oxan-3-yl dodecanoate

C34H62O13 (678.419)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2s,4r,5r)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-2,6,6,10-tetramethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl acetate

C38H62O10 (678.4343)

(3s,5r)-5-[(1s)-1-[(1s,3r,6s,8r,11s,12s,14s,15r,16r)-14-hydroxy-7,7,12,16-tetramethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]-2,2-dimethyloxolan-3-yl acetate

C38H62O10 (678.4343)

[(2r,3s,4s,5r,6r)-6-{[(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-7-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C38H62O10 (678.4343)

15-(4,5-dihydroxy-6-methylhept-6-en-2-yl)-2,6,6,10-tetramethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl acetate

C38H62O10 (678.4343)

[(2r,3s,4s,5r,6r)-6-{[(1s,3r,6s,8s,9s,11r,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C38H62O10 (678.4343)

8-hydroxy-3,10,13,16-tetraisopropyl-2,7,12-trimethyl-6-pentyl-3h,6h,7h,10h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-f]1,10-dioxa-4,7,13,16-tetraazacyclononadecane-1,4,11,14,17-pentone

C36H62N4O8 (678.4567)

(1s,2r,3r,5r,7r,10s,11r,14s,15r)-15-[(2r,4r,5r)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-2,6,6,10-tetramethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl acetate

C38H62O10 (678.4343)

(3s,5as,6s,7s,9as)-6-{2-[(3s,5as,6s,7r,9as)-3,7-bis(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C38H62O10 (678.4343)

(2s,4s,6s,8s,12r,14r,16e,18s,19s)-8-ethyl-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,12,14,18-hexamethyl-9-oxoicosa-10,16-dienoic acid

C40H70O8 (678.507)

9-(acetyloxy)-2,4a,7,7,10a,12a-hexamethyl-2-(3-methylbutan-2-yl)-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,5,6,6a,8,9,10,11,12-decahydro-1h-chrysene-1-carboxylic acid

C38H62O10 (678.4343)

(1s,2r,4r,6s,8s,11s,12s,15r,16r)-16-[(2r,5r)-5-hydroxy-5,6,6-trimethylheptan-2-yl]-7,7,11,15-tetramethyl-8-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,20-dioxahexacyclo[10.6.2.0¹,¹⁵.0²,⁴.0²,¹².0⁶,¹¹]icosan-19-one

C38H62O10 (678.4343)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate

C38H62O10 (678.4343)

(1r,2r,4as,6ar,8r,9r,10as,12as)-9-(acetyloxy)-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-8-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,5,6,6a,8,9,10,11,12-decahydro-1h-chrysene-1-carboxylic acid

C38H62O10 (678.4343)